Discovery Knows No Bounds

Discovery knows no bounds

© Copyright 2019 Regenerative Medicine Minnesota

Derivation of clinical grade transgene-free human iPSC using a newly developed measles reprogramming system for the treatment of diabetes.

Research Grant Recipient: Patricia Devaux, PhD

Grant Period: 2017-2019

Award Value: $250,000

Site: Mayo Clinic

Read Devaux’s Year 1 Progress Report here

Summary: Dr. Devaux is testing a new way of making human blood cells go back to a state from which they can then develop into other kinds of cells, particularly insulin-producing cells that could help diabetic patients

Patricia Devaux, PhD, is an Assistant Professor of Biochemistry and Molecular Biology at Mayo Clinic. She also a researcher with the Gene and Virus Therapy Program, Center for Regenerative Medicine, Mayo Clinic Cancer Center, and Molecular Medicine.

Patricia Devaux portrait